Biomedicines (Nov 2022)

Association between Obesity, Race or Ethnicity, and Luminal Subtypes of Breast Cancer

  • Kalhara R. Menikdiwela,
  • Chanaka Kahathuduwa,
  • Michelle L. Bolner,
  • Rakhshanda Layeequr Rahman,
  • Naima Moustaid-Moussa

DOI
https://doi.org/10.3390/biomedicines10112931
Journal volume & issue
Vol. 10, no. 11
p. 2931

Abstract

Read online

Luminal breast cancers are the most common genomic subtype of breast cancers where Luminal A cancers have a better prognosis than Luminal B. Exposure to sex steroids and inflammatory status due to obesity are key contributors of Luminal tumor development. In this study, 1928 patients with Luminal A breast cancer and 1610 patients with Luminal B breast cancer were compared based on body mass index (BMI), age, race, menopausal status, and expressed receptors (i.e., estrogen (ER), progesterone (PR), and human epidermal growth factor receptor 2 (HER2)). Patients with Luminal B tumors had a significantly higher mean BMI (Δ = 0.69 kgm−2 [0.17, 1.21], p = 0.010) versus Luminal A. Interestingly, the risks of Luminal B tumors were higher among Black/African American patients versus White and Hispanic patients (p p = 0.001, respectively). When controlled for each other, Black/African American race (p p = 0.008) were associated with increased risks of Luminal B carcinoma, while postmenopausal status was associated with a decreased risk (p = 0.028). Increased BMI partially mediated the strong association between Black/African American race and the risk of Luminal B carcinoma. Thus, Black/African American race along with obesity seem to be associated with an increased risk of more aggressive Luminal B breast carcinomas.

Keywords